ISCT Annual Meeting: industry agrees to act on unproven cell and gene therapies

A feature on efforts to protect patients from unscrupulous actors in the cell and gene therapy field.

The potential for cell and gene therapy to save and transform lives is becoming more and more evident, a point observed by Bambi Grilley, chief regulatory officer of the International Society for Cell and Gene Therapy (ISCT), after attending its annual meeting in Paris this month.

This meeting is the largest translation-focused event connecting academic, regulatory and industry experts from around the world to collaborate and solve the most critical issues affecting the development of advanced therapies.